CClinicalTrials.gg
CompletedNCT00065754Updated Sep 20, 2011

Brain Imaging and Pain in Irritable Bowel Syndrome

An interventional study of placebo in Irritable Bowel Syndrome, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2011-09-20.

Sponsored by University of Florida · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study examines the mechanisms, including brain imaging of placebo analgesia

02

Conditions studied

  • Irritable Bowel Syndrome

Keywords

  • Placebo
  • Analgesia
  • Pain
  • Brain mechanism
  • Expectation
03

In context

Irritable Bowel Syndrome

1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.

This study's enrollment of 50 is below the median of 71 across 853 interventional studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Irritable Bowel Syndrome
  • English speaking

Exclusion criteria

Exclusion criteria:

  • Chronic pain condition other than Irritable Bowel Syndrome
  • Medical condition that would contraindicate use of lidocaine
  • Clinical criteria for fibromyalgia
  • Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
  • Seropositive HIV
  • Pregnancy
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double
Enrollment
50 participants

Interventions

  • Drugplacebo
06

Study locations

1 site
  • University of Florida
    Gainesville, Florida 32610, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 20, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00065754
Lead sponsor
University of Florida
Collaborators
National Center for Complementary and Integrative Health (NCCIH), National Institute of Neurological Disorders and Stroke (NINDS)
Responsible party
Sponsor
First posted
Aug 1, 2003
Start date
Sep 2003
Primary completion
Dec 2007
Completion
Dec 2007
Last update
Sep 20, 2011

Study contacts

Michael E Robinson, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion